Druggio

Novartis

Novartis is a pharmaceutical company with a focus on developing and manufacturing innovative medicines, particularly in the areas of oncology, cardiovascular, and respiratory diseases, as well as neuroscience. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has a strong global presence and has developed a wide range of drugs for the treatment of various diseases, including cancer, multiple sclerosis, diabetes, and other serious medical conditions.

Novartis's Drugs

Made by

Approval date

2020/6/29

Treats

Made by

Approval date

2020/6/29

Made by

Approval date

2020/6/29

Treats

Non-small cell lung cancer

Made by

Approval date

2020/6/29

Treats

Made by

Approval date

2020/6/29

Treats

Multiple sclerosis

Made by

Approval date

2020/3/25

Treats

Age-related macular degeneration

Made by

Approval date

2020/3/19

Treats

Spinal muscular atrophy

Made by

Approval date

2019/3/26

Treats

B-cell acute lymphoblastic leukemia, B-cell acute lymphocytic leukemia Primary central nervous system lymphoma

Made by

Approval date

2016/12/19

Treats

Made by

Approval date

2016/9/28

Treats

Cushing syndrome Pituitary gigantism Acromegaly

Made by

Approval date

2016/3/28

Treats

Melanoma Non-small cell lung cancer

Made by

Approval date

2016/3/28

Treats

Non-small cell lung cancer

Made by

Approval date

2016/3/28

Treats

Melanoma Non-small cell lung cancer

Made by

Approval date

2015/7/3

Treats

Multiple myeloma

Made by

Approval date

2014/12/26

Treats

Psoriasis Ankylosing spondylitis, Bechterew disease Pustular psoriasis

Made by

Approval date

2014/7/4

Treats

Polycythemia vera Myelofibrosis

Made by

Approval date

2012/9/28

Treats

Chronic obstructive pulmonary disease (COPD), Emphysema

Imusera, Gilenya

Made by

Novartis Novartis

Approval date

2011/9/26

Treats

Multiple sclerosis

Made by

Approval date

2011/9/26

Treats

Tumor necrosis factor receptor-associated periodic syndrome, Familial periodic fever Cryopyrin associated periodic syndrome Mevalonate kinase deficiency Familial Mediterranean fever, Familial hereditary periodic fever syndromes Familial cold autoinflammatory syndrome, Familial cold urticaria See 1 more disease(s)

Made by

Approval date

2011/7/1

Treats

Chronic obstructive pulmonary disease (COPD), Emphysema

Made by

Novartis Novartis

Approval date

2011/4/22

Treats

Alzheimer disease, Dementia due to Alzheimer disease

Made by

Approval date

2010/1/20

Treats

Type 2 diabetes mellitus

Made by

Approval date

2009/7/7

Treats

High blood pressure, Hypertension

Made by

Approval date

2009/4/22

Treats

Made by

Approval date

2009/1/21

Treats

Age-related macular degeneration Macular edema

Made by

Approval date

2009/1/21

Treats

Allergic rhinitis Asthma

Made by

Approval date

2009/1/21

Treats

Chronic myeloid leukemia

Made by

Approval date

2008/4/16

Made by

Approval date

2007/1/26

Treats

Parkinson disease

Made by

Approval date

2007/1/26

Treats

Subependymal giant cell astrocytoma Breast cancer Allograft rejection Tuberous sclerosis complex, Bourneville-Pringle disease Renal cell carcinoma See 2 more disease(s)

Made by

Approval date

2006/1/23

Treats

Made by

Approval date

2004/10/22

Treats

Multiple myeloma Osteoporosis

Made by

Approval date

2003/10/16

Treats

Age-related macular degeneration

Made by

Approval date

2002/1/17

Treats

Allograft rejection

Made by

Approval date

2001/11/21

Treats

B-cell acute lymphoblastic leukemia, B-cell acute lymphocytic leukemia Hypereosinophilic syndrome Chronic eosinophilic leukemia Chronic myeloid leukemia Gastrotintestinal stromal tumor

Made by

Approval date

2000/9/22

Treats

High blood pressure, Hypertension